6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
An agile launch execution platform, with full visibility across countries and
functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across
countries.
A capability management platform that unifies capabilities, resources, and assessment.
Manage your entire pipeline. Track every move. Stay ahead, from discovery to launch.
Our products
Andre Moa
21 Jan 2025
21 minute read
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.
The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.
US and EU drug approvals for 2019 may be lagging last year’s peaks, but innovation and blockbuster potential are far from exhausted.
Digital transformation has brought benefits but also challenges for pharma launches. With the right software, launch teams can ensure digital works to their advantage.
The right software will help you turn an array of market access challenges for new medicines into competitive differentiation that drives launch success.
In an increasingly networked pharmaceutical market, you can head off access challenges with software that gives full visibility of launch readiness worldwide
With the right digital technology, your launch team can work together to ensure global strategies are leveraged optimally in challenging local environments.
Pharmaceutical companies must embrace pioneering new product launch software if they really want to optimise launch readiness to capitalise on renewed innovation and R&D productivity.
We take a look at the Top 6 Pharma Trends for 2019: From slowing sales growth, biosimilars getting serious, growing pressure on US pricing, more Brexit uncertainty, value focused R&D to the need to address the industry’s ‘me-too’ deficit.
Today’s launch strategies are more modestly scaled, but they must be planned, implemented and tracked in greater depth.
There is plenty of pharmaceutical innovation left in the tank, judging by current product pipelines. Pharma launch challenges, though, have never been tougher.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.